切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2024, Vol. 13 ›› Issue (06) : 883 -888. doi: 10.3877/cma.j.issn.2095-3232.2024995

综述

体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展
袁雨涵1, 杨盛力2,()   
  1. 1.430022 武汉,华中科技大学同济医学院护理学院
    2.430022 武汉,华中科技大学同济医学院附属协和医院肿瘤中心
  • 收稿日期:2024-06-18 出版日期:2024-12-10
  • 通信作者: 杨盛力
  • 基金资助:
    湖北省自然科学基金项目(2023AFB894)

Research progress in proteomic analysis of body fluids and tissues in early molecular diagnosis of liver cancer

Yuhan Yuan1, Shengli Yang2,()   

  1. 1.School of Nursing,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
    2.Cancer Center,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
  • Received:2024-06-18 Published:2024-12-10
  • Corresponding author: Shengli Yang
引用本文:

袁雨涵, 杨盛力. 体液和组织蛋白质组学分析在肝癌早期分子诊断中的研究进展[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 883-888.

Yuhan Yuan, Shengli Yang. Research progress in proteomic analysis of body fluids and tissues in early molecular diagnosis of liver cancer[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2024, 13(06): 883-888.

肝癌是全世界第6位常见恶性肿瘤及第3位肿瘤致死病因,晚期肝癌的预后远远差于早期肝癌,因此对于肝癌的早期诊断和治疗非常重要。目前肝癌早期检测和诊断方式以AFP结合超声检查为主,但这种诊断方法的价值仍然有限。蛋白质组学作为一种新兴的高通量蛋白质研究方式,通过比较生理和病理、疾病不同阶段下体液或组织蛋白组,为寻找潜在新分子标志物提供了新的技术手段。目前主要集中在血浆、肿瘤间质液、组织、肿瘤分泌蛋白、尿液、胆汁、唾液、腹水等体液和组织中蛋白组学的分析,其中血浆和组织仍为蛋白质组学分析的主要对象,分泌蛋白组学、肿瘤间质液蛋白组学分析等也为寻找肝癌的早期分子标志物提供了新的思路。良好的蛋白质组学分析样本的获得是蛋白组学分析的开始,本文综述了体液和组织样本的蛋白质组学分析在肝癌早期分子诊断中的研究进展。

Liver cancer is the sixth most common malignant tumor and the third leading cause of tumor-induced death worldwide. Clinical prognosis of advanced liver cancer is significantly worse than that of early liver cancer. Consequently,early diagnosis and treatment of liver cancer are of significance. At present,AFP detection combined with ultrasound is the main early detection and diagnosis of liver cancer,whereas this diagnostic method has limited value. Proteomics,as a novel high-throughput protein research method,provides a new technical approach for exploring new potential molecular markers by comparing the proteomes of body fluids or tissues at different stages of physiology,pathology and diseases. At present,it mainly focuses on proteomic analysis of the plasma,tumor interstitial fluid,tissues,tumor secreting proteins,urine,bile,saliva,ascites and other body fluids and tissues,among which plasma and tissues remain the main sources of proteomic analysis. In addition,secretory proteomics and proteomic analysis of tumor interstitial fluids also provide novel ideas for identifying early molecular markers of liver cancer. Qualified sample collection is the beginning of proteomic analysis. In this article,research progress in proteomic analysis of body fluid and tissue samples in early molecular diagnosis of liver cancer was reviewed.

[1]
Sung H,Ferlay J,Siegel RL,et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249.
[2]
Cao W,Chen HD,Yu YW,et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J,2021,134(7):783-791.
[3]
中华人民共和国国家卫生健康委员会医政司. 原发性肝癌诊疗指南(2024年版)[J/OL]. 中华肝脏外科手术学电子杂志,2024,13(4):407-449.
[4]
Anderson NL,Anderson NG. Proteome and proteomics: new technologies,new concepts,and new words[J]. Electrophoresis,1998,19(11):1853-1861.
[5]
Nogueira Silva Lima MT,Howsam M,Delayre-Orthez C,et al.Glycated bovine serum albumin for use in feeding trials with animal models - in vitro methodology and characterization of a glycated substrate for modifying feed pellets[J]. Food Chem,2023,428:136815.
[6]
King RM,Gounis MJ,Schmidt EJ,et al. Molecular magnetic resonance imaging of aneurysmal inflammation using a redox active iron complex[J]. Invest Radiol,2023,58(9):656-662.
[7]
Liu T,Joshu CE,Lu J,et al. External validation of genetically predicted protein biomarkers for pancreatic cancer risk using aptamer-based plasma levels: a prospective analysis in the Atherosclerosis Risk in Communities Study[J]. Int J Cancer,2023,153(6):1201-1216.
[8]
Kaur G,Poljak A,Ali SA,et al. Extending the depth of human plasma proteome coverage using simple fractionation techniques[J].J Proteome Res,2021,20(2):1261-1279.
[9]
Zhang Y,Ying X,Zhao Q,et al. Identification of protein expression changes in hepatocellular carcinoma through iTRAQ[J]. Dis Markers,2020: 2632716.
[10]
Nouri-Vaskeh M,Alizadeh L,Hajiasgharzadeh K,et al. The role of HSP90 molecular chaperones in hepatocellular carcinoma[J]. J Cell Physiol,2020,235(12):9110-9120.
[11]
Wang Z,Zhang Z,Zhang Y,et al. MXenes-Au NPs modified electrochemical biosensor for multiple exosome surface proteins analysis[J]. Talanta,2023,265:124848.
[12]
Regin M,Essahib W,Demtschenko A,et al. Lineage segregation in human pre-implantation embryos is specified by YAP1 and TEAD1[J]. Hum Reprod,2023,38(8):1484-1498.
[13]
Bangarh R,Khatana C,Kaur S,et al. Aberrant protein glycosylation:implications on diagnosis and Immunotherapy[J]. Biotechnol Adv,2023,66:108149.
[14]
Hochberg JD,Wirth DM,Pokorski JK. Surface-modified melt coextruded nanofibers enhance blood clotting in vitro[J]. Macromol Biosci,2022,22(12):e2200292.
[15]
Gidwani K,Kekki H,Terävä J,et al. Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results[J]. Mol Aspects Med,2020,72:100831.
[16]
Yin H,Lin Z,Nie S,et al. Mass-selected site-specific corefucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma[J]. J Proteome Res,2014,13(6):2887-2896.
[17]
Liang W,Cong B,Lai W,et al. An electrochemiluminescence resonance energy transfer biosensor based on Luminol-LDH and CuS@Pt for detection of alpha-fetoprotein[J]. Talanta,2023,261:124669.
[18]
Wei F,Su Y,Quan Y,et al. Anticoagulants enhance molecular and cellular immunotherapy of cancer by improving tumor microcirculation structure and function and redistributing tumor infiltrates[J]. Clin Cancer Res,2023,29(13):2525-2539.
[19]
Terkelsen T,Russo F,Gromov P,et al. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer,tumor grade,and immune infiltration[J]. Breast Cancer Res,2020,22(1):73.
[20]
Wang L,Wu X,Ruan Y,et al. Exosome-transmitted hsa_circ_0012634 suppresses pancreatic ductal adenocarcinoma progression through regulating miR-147b/HIPK2 axis[J]. Cancer Biol Ther,2023,24(1):2218514.
[21]
Matas-Nadal C,Bech-Serra JJ,Guasch-Vallés M,et al. Evaluation of tumor interstitial fluid-extraction methods for proteome analysis:comparison of biopsy elution versus centrifugation[J]. J Proteome Res,2020,19(7):2598-2605.
[22]
Hajji M,Hamdi M,Sellimi S,et al. Structural characterization,antioxidant and antibacterial activities of a novel polysaccharide from Periploca laevigata root barks[J]. Carbohydr Polym,2019,206:380-388.
[23]
Zhang J,Hao N,Liu W,et al. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery[J]. Br J Cancer,2017,117(11):1676-1684.
[24]
Sun W,Xing B,Guo L,et al. Quantitative proteomics analysis of tissue interstitial fluid for identification of novel serum candidate diagnostic marker for hepatocellular carcinoma[J]. Sci Rep,2016,6:26499.
[25]
Dani S,Kumar R,Sharma H,et al. Integrated experimental and theoretical studies on structural and magnetic properties of thin films of double perovskite ruthenates: Ba2DyRuO6 & Sr2DyRuO6[J].Phys Chem Chem Phys,2023,25(31):20863-20870.
[26]
Dmowski M,Makiela-Dzbenska K,Sharma S,et al. Impairment of the non-catalytic subunit Dpb2 of DNA Pol ɛ results in increased involvement of Pol δ on the leading strand[J]. DNA Repair,2023,129:103541.
[27]
Wang LH,Cao B,Li YL,et al. Potential prognostic and therapeutic value of ANXA8 in renal cell carcinoma: based on the comprehensive analysis of annexins family[J]. BMC Cancer,2023,23(1):674.
[28]
Zhao CC,Yu WW,Qi YJ,et al. Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cells[J]. Anticancer Drugs,2020,31(3):223-230.
[29]
Sheng D,Zhao B,Zhu W,et al. Scutellaria barbata D.Don (SBD)extracts suppressed tumor growth,metastasis and angiogenesis in Prostate cancer via PI3K/Akt pathway[J]. BMC Complement Med Ther,2022,22(1):120.
[30]
Xing X,Yuan H,Liu H,et al. Quantitative secretome analysis reveals clinical values of carbonic anhydrase Ⅱ in hepatocellular carcinoma[J]. Genomics Proteomics Bioinformatics,2021,19(1):94-107.
[31]
Seay TW,Suo Z. Roles of extracellular vesicles on the progression and metastasis of hepatocellular carcinoma[J]. Cells,2023,12(14):1879.
[32]
Uzzaman A,Zhang X,Qiao Z,et al. Discovery of small extracellular vesicle proteins from human serum for liver cirrhosis and liver cancer[J]. Biochimie,2020,177:132-141.
[33]
Alic L,Binder CJ,Papac-Milicevic N. The OSE complotype and its clinical potential[J]. Front Immunol,2022,13:1010893.
[34]
Sahebi R,Langari H,Fathinezhad Z,et al. Exosomes: new insights into cancer mechanisms[J]. J Cell Biochem,2020,121(1):7-16.
[35]
Thuya WL,Kong LR,Syn NL,et al. FAM3C in circulating tumorderived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites[J]. Theranostics,2023,13(2):621-638.
[36]
Whiteside TL. Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell[J]. Expert Rev Mol Diagn,2023,23(2):109-122.
[37]
Feng J,Xiu Q,Huang Y,et al. Plant-derived vesicle-like nanoparticles as promising biotherapeutic tools: present and future[J].Adv Mater,2023,35(24):e2207826.
[38]
Portales AE,Miguel I,Rodriguez MJ,et al. CDK4/6 are necessary for UCP1-mediated thermogenesis of white adipose tissue[J]. Life Sci,2023,322:121652.
[39]
Nimitrungtawee N,Inmutto N,Chattipakorn SC,et al. Extracellular vesicles as a new hope for diagnosis and therapeutic intervention for hepatocellular carcinoma[J]. Cancer Med,2021,10(23):8253-8271.
[40]
de Paepe J,Garcia Gragera D,Arnau Jimenez C,et al. Continuous cultivation of microalgae yields high nutrient recovery from nitrified urine with limited supplementation[J]. J Environ Manage,2023,345:118500.
[41]
Sun Y,Guan B,Liu X,et al. Screening for urinary markers predicting hematopoietic stem cell injury induced by busulfan using genetically diverse mice[J]. Animal Model Exp Med,2023,6(2):146-154.
[42]
Kiernan E,Surapaneni A,Zhou L,et al. Alterations in the circulating proteome associated with albuminuria[J]. J Am Soc Nephrol,2023,34(6):1078-1089.
[43]
Sirirungreung A,Hansen J,Ritz B,et al. Association between medically diagnosed postnatal infection and childhood cancers:a matched case-control study in Denmark,1978 to 2016[J]. Int J Cancer,2023,153(5):994-1002.
[44]
Zhao Y,Li Y,Liu W,et al. Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics[J]. J Proteomics,2020,225:103780.
[45]
Ramos-Campoy O,Lladó A,Bosch B,et al. Differential gene expression in sporadic and genetic forms of Alzheimer's disease and frontotemporal dementia in brain tissue and lymphoblastoid cell lines[J]. Mol Neurobiol,2022,59(10):6411-6428.
[46]
Lian X,Zhang W,He-Yang J,et al. Human milk oligosaccharide disialyllacto-n-tetraose protects human intestinal epithelium integrity and permeability against mast cell chymase-induced disruption by stabilizing ZO-1/FAK/P38 pathway of intestinal epithelial cell[J].Immunopharmacol Immunotoxicol,2023,45(4):409-418.
[47]
Ikeda C,Haga H,Makino N,et al. Utility of Claudin-3 in extracellular vesicles from human bile as biomarkers of cholangiocarcinoma[J].Sci Rep,2021,11(1):1195.
[48]
Swain AK,Pandey P,Sera R,et al. Single-cell transcriptome analysis identifies novel biomarkers involved in major liver cancer subtypes[J]. Funct Integr Genomics,2023,23(3):235.
[49]
Shimi G,Sohrab G,Pourvali K,et al. Correlation of low levels of α-1 antitrypsin and elevation of neutrophil to lymphocyte ratio with higher mortality in severe COVID-19 patients[J]. Mediat Inflamm,2021: 5555619.
[50]
Boroumand M,Olianas A,Cabras T,et al. Saliva,a bodily fluid with recognized and potential diagnostic applications[J]. J Sep Sci,2021,44(19):3677-3690.
[51]
Silumbwe A,San Sebastian M,Zulu JM,et al. The role of principled engagement in public health policymaking: the case of Zambia's prolonged efforts to develop a comprehensive tobacco control policy[J]. Glob Health Action,2023,16(1):2212959.
[52]
Ford CE,Werner B,Hacker NF,et al. The untapped potential of ascites in ovarian cancer research and treatment[J]. Br J Cancer,2020,123(1):9-16.
[53]
Hsi TC,Ong KL,Sepers JJ,et al. Systemic coagulopathy promotes host lethality in a new Drosophila tumor model[J]. Curr Biol,2023,33(14):3002-3010,e6.
[54]
Yu P,Chen W,Ge L,et al. Logic gate-driven dual-index balanced visualization strategy for tumor metastasis diagnosis[J]. Biosens Bioelectron,2023,237:115556.
[55]
Kitamura F,Miyata T,Uemura N,et al. Proteomic analysis of malignant ascites from patients with pancreatic ductal adenocarcinoma[J]. Anticancer Res,2021,41(6):2895-2900.
[56]
Yoshizawa Y,Nakao T,Tsuritani K,et al. The importance of specific citrullinated clusterin and vimentin found in a multi-coloured beadbased citrulline-peptide array system in rheumatoid arthritis[J]. Clin Exp Rheumatol,2022,40(5):936-944.
[1] 刘政宏, 袁春銮. 乳腺癌患者血清外泌体中长链非编码RNA BC200的表达及临床意义[J]. 中华乳腺病杂志(电子版), 2024, 18(04): 212-216.
[2] 何淳诺, 田志敏, 李焕玺, 吴昊越, 庄凯鹏, 周胜虎, 张浩强. 小儿发育性髋关节发育不良诊治的研究进展[J]. 中华关节外科杂志(电子版), 2024, 18(04): 497-504.
[3] 中国医师协会肝癌专业委员会. 肝细胞癌伴微血管侵犯诊断和治疗中国专家共识(2024版)[J]. 中华普通外科学文献(电子版), 2024, 18(05): 313-324.
[4] 唐梅, 周丽, 牛岑月, 周小童, 王倩. ICG荧光导航的腹腔镜肝切除术临床意义[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 655-658.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[7] 林巧, 周丽. RFA联合LAH术治疗原发性肝癌并门静脉癌栓的临床效果分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 521-524.
[8] 曾繁利, 齐秩凯, 杨贺庆. 两种经Glisson蒂鞘解剖路径肝切除术治疗原发性肝癌的肿瘤学疗效及风险比对[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 525-527.
[9] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[10] 李一帆, 朱帝文, 任伟新, 鲍应军, 顾俊鹏, 张海潇, 曹耿飞, 阿斯哈尔·哈斯木, 纪卫政. 血GP73水平在原发性肝癌TACE疗效评价中的作用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 825-830.
[11] 刘敏思, 李荣, 李媚. 基于GGT与Plt比值的模型在HBV相关肝细胞癌诊断中的作用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 831-835.
[12] 焦振东, 惠鹏, 金上博. 三维可视化结合ICG显像技术在腹腔镜肝切除术治疗复发性肝癌中的应用[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 859-864.
[13] 陈晓鹏, 王佳妮, 练庆海, 杨九妹. 肝细胞癌VOPP1表达及其与预后的关系[J]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 876-882.
[14] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[15] 王向前, 李清峰, 陈磊, 丘文丹, 姚志成, 李熠, 吴荣焕. 姜黄素抑制肝细胞癌索拉非尼耐药作用及其调控机制[J]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 729-735.
阅读次数
全文


摘要